[Interview] Dr. Reiko Arita, Ophthalmologist, Discusses the Potential of “TLM-001,” a Candidate Drug for Meibomian Gland Dysfunction Being Developed by the Tsubota Lab
Financial Results Briefing for the First Quarter of the Fiscal Year Ending March 2027
[ReLight Tech] Here’s a look at our display prototype!
The latest AI tool, Gemini Notebook (formerly NotebookLM), is amazing! Here’s how we use it at the Tsubota Lab.
Tsubota Lab Employee Introduction⑩：Mr. Mizan, Research and Development Headquarters
[5th Open Campus] Tsubota Lab Innovation Update 2026
MediProduce, Inc. Joins the Tsubota Laboratory Group
[Global Paper Series No. 15]Does Choroidal Macrophage Polarization Regulate the Onset and Progression of Myopia?
We announced our new technology, “ReLight Tech,” at SID Display Week!
Details regarding our fundraising announcement published on June 1, 2026.
